Risk Prediction and Therapy Monitoring in Patients With SARS-Cov-2 Infection / COVID 19 (CROWNLESS)

Heidelberg University

Status: Unknown

Conditions: COVID; SARS-CoV2

Study type: Observational

Funder types: Other

Identifiers

NCT04456075

CROWNLESS

Details and patient eligibility

About

Approximately 15% of patients with SARS-CoV-2 infection / COVID-19 develop a severe clinical course. This leads to hospitalization and potentially life threatening complications such as pneumonia and respiratory failure. Predictors for early detection and risk stratification are urgently needed. Moreover, only scarce information is available for long-term follow-up and late complications associated with infection. We therefore aimed to find predictors for severe courses of the novel disease as well as to establish strategies for therapeutic monitoring and follow-up.

Enrollment: 100 estimated patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• SARS-CoV-2 infection / COVID 19

Exclusion criteria

• invasive ventilation
• respiratory failure at admission